Getein Biotech, Inc (603387.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
1947
First IPO Date
July 17, 2017
| Name | Title | Pay | Year Born |
| Enben Su | Chairman & GM | 0 | 1966 |
| Wen Ni | Accounting Supervisor, Financial Director & Director | 0 | 1983 |
| Tingting Kong | Deputy GM & Director | 0 | 1984 |
| Bin Yan | Deputy GM & Director | 0 | 1982 |
| Cong Liu | Secretary of the Board of Directors | 0 | 1986 |
Getein Biotech, Inc. is an enterprise primarily focused on the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) solutions. Founded in 2002 and based in Nanjing, China, the company offers a comprehensive array of diagnostic products. This includes a variety of diagnostic reagents, advanced analytical instruments, and crucial calibrators. Getein also supplies foundational raw materials for reagents, such as monoclonal and polyclonal antibodies, antigens, antiserum, and microspheres. Its extensive product line caters to diverse medical fields, encompassing diagnostics for cardiac markers, inflammatory conditions, renal function, blood coagulation, thyroid disorders, fertility assessments, diabetes care, and thrombus detection. These offerings broadly serve applications in cardiovascular, inflammatory, diabetes, reproductive, renal, hepatic, and other key health areas.